Open-label trial on efficacy of artemether/lumefantrine against the uncomplicated <em>Plasmodium falciparum</em> malaria in Metema district, Northwestern Ethiopia

Abstract

The study showed high efficacy and tolerability of Coartem(®) against uncomplicated P. falciparum malaria, suggesting the continuation as a first-line drug in the study district. However, regular monitoring of the therapeutic efficacy of the drug, possibly with plasma drug-level measurement, is critical among the mobile border population.